TCRT: Alaunos Therapeutics, Inc. Stock

by  •  • Comments Off on TCRT: Alaunos Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.61
Enterprise Value ($M) 3.52
Book Value ($M) 2.06
Book Value / Share 1.29
Price / Book 2.24
NCAV ($M) 2.06
NCAV / Share 1.29
Price / NCAV 2.24

Profitability (mra)
Return on Invested Capital (ROIC) -2.27
Return on Assets (ROA) -0.78
Return on Equity (ROE) -0.98

Liquidity (mrq)
Quick Ratio 3.98
Current Ratio 3.98

Balance Sheet (mrq) ($M)
Current Assets 2.75
Assets 2.75
Liabilities 0.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.01
Operating Income -4.81
Net Income -4.68
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.97
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A MSD Partners, L.P. 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A (Amendment No. 1)
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 1,046 11,073 9.45
2025-05-12 21 6,969 0.30
2025-05-09 2,607 15,621 16.69
2025-05-08 4,501 24,050 18.72

(click for more detail)

Similar Companies
SXTC – China SXT Pharmaceuticals, Inc. SXTP – 60 Degrees Pharmaceuticals, Inc.
SYBX – Synlogic, Inc. TELO – Telomir Pharmaceuticals, Inc.
TENX – Tenax Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io